Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

BUY
$278.73 - $327.27 $222,984 - $261,816
800 New
800 $259,000
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $187,752 - $233,328
-800 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $1.1 Million - $1.37 Million
-4,900 Reduced 85.96%
800 $221,000
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $131,852 - $162,262
-595 Reduced 9.45%
5,700 $1.32 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $1.14 Million - $1.47 Million
6,295 New
6,295 $1.45 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $279,179 - $361,411
-1,699 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $221,651 - $293,298
1,699 New
1,699 $287,000
Q2 2020

Aug 06, 2020

SELL
$136.42 - $164.18 $416,080 - $500,749
-3,050 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$119.05 - $147.35 $363,102 - $449,417
3,050 New
3,050 $385,000
Q4 2019

Feb 11, 2020

SELL
$106.92 - $132.43 $224,532 - $278,103
-2,100 Closed
0 $0
Q3 2019

Oct 16, 2019

SELL
$106.79 - $116.16 $1.44 Million - $1.57 Million
-13,500 Reduced 86.54%
2,100 $235,000
Q2 2019

Aug 05, 2019

BUY
$110.79 - $129.32 $1.73 Million - $2.02 Million
15,600 New
15,600 $1.83 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Enlightenment Research, LLC Portfolio

Follow Enlightenment Research, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Enlightenment Research, LLC with notifications on news.